Literature DB >> 2372769

Plasma prolactin as an indicator of disease progression in advanced breast cancer.

J M Bhatavdekar1, N G Shah, D B Balar, D D Patel, A Bhaduri, S N Trivedi, N H Karelia, N Ghosh, M K Shukla, D D Giri.   

Abstract

Serial plasma prolactin levels were measured in 144 breast cancer patients (premenopausal [PR-M], N = 64; postmenopausal [PO-M], N = 80) and compared with respective controls. Patients with breast cancer were grouped into those who (1) developed distant metastasis, (2) developed local recurrence, (3) stable disease, and (4) responded to the various therapeutic modalities at the end of 2 years. The authors' analysis showed excellent correlation between serial plasma prolactin changes and the response to therapy or progression of disease in patients with advanced breast carcinoma.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2372769     DOI： 10.1002/1097-0142(19900501)65:9<2028::aid-cncr2820650924>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  15 in total

1.  Absence of prolactin gene expression in colorectal cancer.

Authors:  A J Wood; C M Thomas; K R Baumforth; J R Flavell; K W Scott; R H Grace; J G Williams; M R Holland; R Dunn; A G Jacobs; A Harrison; S Brun; N Plessis; P G Murray
Journal:  Mol Pathol       Date:  1999-06

2.  Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.

Authors:  Katherine M Harrington; Charles V Clevenger
Journal:  J Biol Chem       Date:  2016-08-03       Impact factor: 5.157

3.  Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.

Authors:  Karen J Wernli; John M Hampton; Amy Trentham-Dietz; Polly A Newcomb
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11-08       Impact factor: 2.890

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 5.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  Plasma and tumor prolactin in colorectal cancer patients.

Authors:  Y Ilan; O Sibirsky; N Livni; O Gofrit; V Barack; E Goldin
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.

Authors:  K A O'Leary; D E Rugowski; R Sullivan; L A Schuler
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

8.  Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.

Authors:  J M Bhatavdekar; D D Patel; N H Karelia; H H Vora; N Ghosh; N G Shah; D B Balar; S N Trivedi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 9.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

10.  The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.

Authors:  Ashley Sutherland; Amanda Forsyth; Yingying Cong; Laurel Grant; Tzu-Hua Juan; Jae K Lee; Alexander Klimowicz; Stephanie K Petrillo; Jinghui Hu; Angela Chan; Florence Boutillon; Vincent Goffin; Cay Egan; Patricia A Tang; Li Cai; Don Morris; Anthony Magliocco; Carrie S Shemanko
Journal:  J Natl Cancer Inst       Date:  2015-11-19       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.